The effects of Nimesulide combined with cisplatin on lung cancer

Summary To study the effects of cyclooxygenase 2 selective inhibitor Nimesulide (NIM) combined with Cisplatin (DDP) on human lung cancer and the possible mechanisms, the proliferation and appoptosis of human lung cancer cell line A549 were evaluated by MTT reduction assay and flow cytometry respectively. The inhibitory effect on neoplasia in vivo was tested on nude mice subcutaneously implanted tumor. Our results showed that NIM and DDP could inhibit A549 cell proliferation in a concentration-dependent pattern; this action was enhanced when NIM (25 μmol/L) was given in combination with DDP and they worked in a synergistic or additive pattern as DDP concentration ≥1 μg/ml. NIM and DDP could induce A549 cells apoptosis and the action was augmented when used in combination ( P <0.01). NIM and DDP could inhibit the growth of subcutaneously implanted tumors on nude mice ( P <0.05, P <0.01) and the inhibitory rate of NIM combined with DDP was significantly higher than that of NIM or DDP group ( P <0.01, P <0.01). It is concluded that combined use of NIM and DDP has significant synergistic antitumor effects on lung cancer cell line A549 and in animals in vivo . The synergy may be achieved by growth inhibition and apoptosis induction.